The annual newborn blood spot screening data collection and performance analysis report for the year 1 April 2016 to 31 March 2017.
Fateha has 17 years' experience in the field of public health, policy and data collection, focused primarily on health protection, epidemiology and surveillance. She joined PHE Screening on secondment as a screening data and information manager for the NHS Newborn Blood Spot Screening Programme. Her substantive post is as as senior data analyst within the London and South East regional team of the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS).
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021